Switzerland’s Spiez Laboratory at the heart of WHO’s BioHub system
The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing of viruses and other pathogens…
Biopôle’s Start-Up Fund aims to promote early access to innovation in life…
Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sciences entrepreneurs. With the creation of the…
Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million
A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round. Headquartered at the EPFL Innovation Park…
Berna Biotech Pharma and Swiss Biotech Center to develop second-generation…
Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19. The goal is to conduct clinical trials by fall 2021.…
Ferring Biologics Innovation Center opens at Biopôle
Swedish biopharmaceutical group Ferring Pharmaceuticals has opened a state-of-the-art innovation center at Biopôle, adding a new hub for biologics research and development to the vibrant life sciences campus located…
Medtech company MedAlliance raises over USD 50 million to commercialize…
Vaud-based MedAlliance has raised over USD 50 Million in equity funding for its novel balloon that provides a controlled sustained release of a limus drug. This financing will be…
Tech4Eva, the first Swiss start-up accelerator addressing women’s health
The EPFL Innovation Park and Groupe Mutuel are joining forces to launch Tech4Eva, the first start-up acceleration program in Switzerland addressing women’s health. Studies indicate that…
Bern scientists develop individualized cancer models to predict therapy success
Scientists at the University of Bern and Inselspital have established organoid culture models from prostate tumor biopsies. These are small clusters of cells which can be used to test the…
HES-SO Valais-Wallis will contribute to the world’s largest database of…
As part of the Horizon 2020 research program, the European project BIGPICTURE, to which the HES-SO Valais-Wallis is contributing, aims to build the world’s largest database of histopathological images.…
Lausanne University Hospital ranked among the ten best hospitals worldwide
After a particularly challenging year for hospitals, the prestigious U.S. magazine Newsweek has once again included the Lausanne University Hospital (CHUV) in its list of the ten best hospitals in…
Debiopharm enters EUR 900+ million contract with Merck
Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and neck cancer treatment drug. Debiopharm, a global biopharmaceutical company…
Accurately assessing the transmissibility of new coronavirus mutants
An international team involving researchers from the Institute of Virology and Immunology (IVI) of the Federal Food Safety and Veterinary Office BLV and the University of Bern, the Centers…